Trial Outcomes & Findings for Endovascular Repair for the Descending Thoracic Aorta (NCT NCT02376998)
NCT ID: NCT02376998
Last Updated: 2016-10-07
Results Overview
Evaluation of mortality, renal failure, cerebrovascular accident.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
20 participants
Primary outcome timeframe
from hospital discharge to 1 month after the procedure
Results posted on
2016-10-07
Participant Flow
Participant milestones
| Measure |
Patients With Acute Transection of Thoracic Aorta
Patients with a diagnosis of acute transection of thoracic aorta.
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
11
|
|
Overall Study
NOT COMPLETED
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Endovascular Repair for the Descending Thoracic Aorta
Baseline characteristics by cohort
| Measure |
Patients With Acute Transection of Thoracic Aorta
n=11 Participants
Patients with a diagnosis of acute transection of thoracic aorta.
|
|---|---|
|
Age, Continuous
|
36.9 years
n=99 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=99 Participants
|
|
Region of Enrollment
Italy
|
11 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: from hospital discharge to 1 month after the procedurePopulation: No serious adverse events recorded
Evaluation of mortality, renal failure, cerebrovascular accident.
Outcome measures
| Measure |
Patients With Acute Transection of Thoracic Aorta
n=11 Participants
Patients with a diagnosis of acute transection of thoracic aorta. Mortality 0%
|
|---|---|
|
Number of Participants With Major Adverse Events
|
0 number of serious adverse events
|
Adverse Events
Valiantâ„¢ Endoluminal Procedure
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Prof. Raffaele Serra
University Magna Graecia of Catanzaro
Phone: +3909613647380
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place